Form 4: Health Catalyst COO Daniel LeSueur Reports Acquisition of Common Stock and Restricted Stock Units

Daniel LeSueur, COO of Health Catalyst, reports the acquisition of common stock and restricted stock units (RSUs) and performance-based restricted units (PRSUs) on February 20, 2025.

Summary

• On February 20, 2025, Daniel LeSueur, the Chief Operating Officer of Health Catalyst, Inc., reported the acquisition of 145,000 restricted stock units (RSUs) and 11,340 performance-based restricted units (PRSUs).
• These transactions increased LeSueur's direct holdings to 242,384 shares of common stock.
• The RSUs were granted under the company's 2019 Stock Option and Incentive Plan.
• 33.33% of the RSUs will vest on December 1, 2025, with the remaining 66.67% vesting in 8 equal quarterly installments.
• The PRSUs were awarded based on the company's performance criteria for the fiscal year ended December 31, 2024.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices and alignment of interests. There are no explicitly negative elements.

Positives

• The grant of RSUs and PRSUs to the COO aligns his interests with those of the shareholders.
• The vesting schedule of the RSUs encourages long-term commitment from the COO.
• The PRSUs are tied to company performance, incentivizing the COO to achieve specific goals.

Future Outlook

The vesting schedule of the RSUs extends into the future, suggesting a continued alignment of the COO's interests with the company's long-term performance.

Industry Context

Stock grants and equity-based compensation are common practices in the technology industry to attract, retain, and incentivize key executives.

Comparison to Industry Standards

• Companies like Datadog, Snowflake, and MongoDB also utilize stock options and restricted stock units as part of their executive compensation packages.
• The vesting schedules and performance-based components are generally aligned with industry norms to ensure long-term commitment and performance alignment.
• The specific amounts and terms of these grants vary based on company size, performance, and individual executive roles.

Stakeholder Impact

• The stock grants align management's interests with shareholders, potentially driving long-term value.
• Employees may view the grants as a positive sign of the company's commitment to its leadership.
• The grants have no immediate impact on customers, suppliers, or creditors.

Key Dates

Keywords

Health Catalyst, Daniel LeSueur, RSU, PRSU, Stock Options, Beneficial Ownership, Form 4, HCAT, COO